Breast Cancer Diagnostics Market

Global Breast Cancer Diagnostics Market Size, Trends, and Analysis - Forecasts To 2026 By Product (Instrument-based [Biopsy and Imaging] and Platform-based [PCR, Next-generation Sequencing, Microarrays, and Others]), By Type (Blood Tests, Biopsy, Imaging, Genomic Tests, and Others), By Application (Prognostic, Diagnostic & Predictive, Screening, and Research), By End-Use (Diagnostic Centers & Medical Laboratories, Hospitals & Clinics, and Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 13 2024 with the latest and most recent market numbers

Breast Cancer Diagnostics Market Size

The global breast cancer diagnostics market is projected to grow from USD 4.8 billion in 2021 and is expected to reach USD 7.5 billion by 2026 at a CAGR of 6.9% from 2021 to 2026. In the modern era, breast cancer is termed to be the second most common cancer type after skin cancer in United States women. The American Cancer Society estimates that over 280,000 new cases of breast and over 49,000 breast cancer-related deaths were registered in 2021 in the United States.

The growing awareness for breast cancer across the globe because of the increasing awareness campaigns by international organisations, rising research for diagnostics due to increasing investments from the government as well as non-government sector, and increasing number of survivals due to early diagnosis leading to better acceptance of the procedure in the world, are the key drivers of the breast cancer diagnostics market. The studies have shown that the cases of breast cancer in women are common and cases have seen a rapid increase in the age group of 25 to 38 years. This increasing rate of breast cancer has pushed the world economy to explore the diagnostic procedures for breast cancer. This provides the scope for the market to penetrate the global economy.

Early diagnosis of breast cancer is important to save lives, as early diagnosis can give more time for better treatment, resulting in heavy investment in the development of novel diagnostic techniques.

global breast cancer diagnostics market

Breast Cancer Diagnostics Market: By Product

Based on the different types of products offered under breast cancer diagnostics, the market is segmented into instrument-based products and platform-based products. The platform-based segment is predicted to be the dominating segment in the market for breast cancer. The segment can be further divided into PCR, next-generation sequencing, microarrays, and others. Continuous innovation in the segment for better products with changing technology is the major factor responsible for the domination of this segment.

The instrument-based segment is forecasted to be the fastest-growing segment in the market. The segment can be further classified into biopsy and imaging. Imaging diagnostics such as mammography, ultrasonography, and MRI, among others are the most common method of breast cancer diagnosis. The growing incidence of breast cancer globally, coupled with rising demand for technologically sound diagnostic methods are the main drivers of the segment’s growth during the forecast period. The diagnostic done by imaging helps in analyzing the cancer stage and disease expansion area.

Breast Cancer Diagnostics Market: By Type

Based on the types of diagnostics, the breast cancer diagnostics market can be segmented into blood tests, biopsy, imaging, genomic tests, and others. The most common type of diagnostic is termed to be the imaging segment due to which the segment holds the largest share in the market. The ease of availability and increasing research for better service of this diagnostic type are fueling growth in the market.

Ultrasonography, mammography, and breast magnetic resonance imaging are the different types of imaging procedures that are used to diagnose the disease and decide on future treatment. The increasing level of awareness among people in developing countries as the cases of breast cancer are becoming common in females is also helping people globally to approach the right medical diagnostic technique. The segment of biopsy in the market is also anticipated to witness decent growth during the forecast period.

Breast Cancer Diagnostics Market: By Application

Based on the application, the breast cancer diagnostics market can be segmented into prognostic, diagnostic & predictive, screening, and research. The largest shareholder segment in the market of breast cancer diagnostics is the diagnostic & predictive segment. The innovation in the segment with increasing investment and research, genetic testing trend explosion globally due to growing awareness for breast cancer diagnosis are the key drivers of this domination. Genetic testing is popular because this testing analysis the changes in a person’s DNA so that the pattern can be interpreted to see if breast cancer risk is present or not.

The segment of prognostic in the breast cancer diagnostics market is projected to register the fastest CAGR during the forecast period. The factors such as the rising rate of survival due to prognostic, increasing awareness globally for breast cancer, and the importance of the prognostic application to prepare the accurate and effective treatment or therapy are helping the prognostic segment to grow.

Breast Cancer Diagnostics Market: By End-Use

Based on the end-use of the diagnostics, the breast cancer diagnostic market can be segmented into diagnostic centres & medical laboratories, hospitals & clinics, and others. The highest share is occupied by the hospitals & clinics segment in the market. Availability of various diagnostic elements with proper treatment and facility of hospitalization if needed are the major factors helping the segment to propel.

The segment of diagnostic centres & medical laboratories is anticipated to grow at a stable pace in the breast cancer diagnostics market. The growing number of diagnostic centres due to continuous efforts from governments of various countries and rising collaborations between laboratories and hospitals is resulting in the growth of this segment. Several laboratories are in charge of diagnostic procedures which are approved by hospitals so that hospitals can function efficiently by distributing their diagnostic work to laboratories.

asia pacific breast cancer diagnostics market

Breast Cancer Diagnostics Market: By Region

As per the geographical analysis, the market can be classified into North America, Europe, Central, and South America, the Middle East and Africa, and the Asia Pacific regions. The Asia Pacific region will be the fastest-growing region in terms of market value from 2021-2026. The growing penetration of new technologies in the region with improving infrastructure of the healthcare sector, increasing awareness for early diagnosis to avoid difficulties in the treatment, and rising cases of breast cancer are the main drivers for the growth of this region.

The number of breast cancer in South Korea, Singapore and Japan are rising because of which the governments of these nations are taking initiatives for increasing the diagnostic centres in their respective countries.

The North American region is predicted to be the largest shareholder in the market of breast cancer diagnostics. Contrary to the Asia Pacific region, North America has a developed infrastructure of diagnostic centres which helps the region to reach out to a broader range of people in the region. The well-established market with important market players also helps the region to spread awareness and introduce new technologies.

Breast Cancer Diagnostics Market Share & Competitor Analysis

F. Hoffmann-La Roche Ltd., Genomic Health, Hologic Inc., Danaher, Argon Medical Devices, Inc., BD, QIAGEN, Koninklijke Philips N.V., Myriad Genetics, and Thermo Fisher Scientific Inc., among others, are the major vendors in the breast cancer diagnostics market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Breast Cancer Diagnostics Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 Type Overview

2.1.3 Product Overview

2.1.4 End-User Overview

2.1.5 Application Overview

2.1.6 Regional Overview

Chapter 3 Breast Cancer Diagnostics Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Advancements in the cancer diagnsotics

3.3.1.2 Growing investment in cancer research

3.3.2 Industry Challenges

3.3.2.1 High cost of diagnostic equipment and treatment

3.4 Prospective Growth Scenario

3.4.1 Type Growth Scenario

3.4.2 Product Growth Scenario

3.4.3 End-User Growth Scenario

3.4.4 Application Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Application Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Breast Cancer Diagnostics Market, By Type

4.1 Type Outlook

4.2 Instrument-based

4.2.1 Market Size, By Region, 2020-2026 (USD Billion)

4.3 Platform-based

4.3.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 5 Breast Cancer Diagnostics Market, By End-User

5.1 End-User Outlook

5.2 Diagnostic Centers & Medical Laboratories

5.2.1 Market Size, By Region, 2020-2026 (USD Billion)

5.3 Hospitals & Clinics

5.3.1 Market Size, By Region, 2020-2026 (USD Billion)

5.4 Others

5.4.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 6 Breast Cancer Diagnostics Market, By Product

6.1 Blood Tests

6.1.1 Market Size, By Region, 2020-2026 (USD Billion)

6.2 Biopsy

6.2.1 Market Size, By Region, 2020-2026 (USD Billion)

6.3 Imaging

6.3.1 Market Size, By Region, 2020-2026 (USD Billion)

6.4 Genomic Tests

6.4.1 Market Size, By Region, 2020-2026 (USD Billion)

6.5 Others

6.5.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 7 Breast Cancer Diagnostics Market, By Application

7.1 Prognostic

7.1.1 Market Size, By Region, 2020-2026 (USD Billion)

7.2 Diagnostic & Predictive

7.2.1 Market Size, By Region, 2020-2026 (USD Billion)

7.3 Screening

7.3.1 Market Size, By Region, 2020-2026 (USD Billion)

7.4 Research

7.4.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 8 Breast Cancer Diagnostics Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2020-2026 (USD Billion)

8.2.2 Market Size, By Type, 2020-2026 (USD Billion)

8.2.3 Market Size, By Product, 2020-2026 (USD Billion)

8.2.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.2.5 Market Size, By Application, 2020-2026 (USD Billion)

8.2.6 U.S.

8.2.6.1 Market Size, By Type, 2020-2026 (USD Billion)

8.2.4.2 Market Size, By Product, 2020-2026 (USD Billion)

8.2.4.3 Market Size, By End-User, 2020-2026 (USD Billion)

Market Size, By Application, 2020-2026 (USD Billion)

8.2.7 Canada

8.2.7.1 Market Size, By Type, 2020-2026 (USD Billion)

8.2.7.2 Market Size, By Product, 2020-2026 (USD Billion)

8.2.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.2.7.4 Market Size, By Application, 2020-2026 (USD Billion)

8.3 Europe

8.3.1 Market Size, By Country 2020-2026 (USD Billion)

8.3.2 Market Size, By Type, 2020-2026 (USD Billion)

8.3.3 Market Size, By Product, 2020-2026 (USD Billion)

8.3.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.5 Market Size, By Application, 2020-2026 (USD Billion)

8.3.6 Germany

8.3.6.1 Market Size, By Type, 2020-2026 (USD Billion)

8.3.6.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.6.4 Market Size, By Application, 2020-2026 (USD Billion)

8.3.7 UK

8.3.7.1 Market Size, By Type, 2020-2026 (USD Billion)

8.3.7.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.7.4 Market Size, By Application, 2020-2026 (USD Billion)

8.3.8 France

8.3.8.1 Market Size, By Type, 2020-2026 (USD Billion)

8.3.8.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.8.4 Market Size, By Application, 2020-2026 (USD Billion)

8.3.9 Italy

8.3.9.1 Market Size, By Type, 2020-2026 (USD Billion)

8.3.9.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.9.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.9.4 Market Size, By Application, 2020-2026 (USD Billion)

8.3.10 Spain

8.3.10.1 Market Size, By Type, 2020-2026 (USD Billion)

8.3.10.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.10.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.10.4 Market Size, By Application, 2020-2026 (USD Billion)

8.3.11 Russia

8.3.11.1 Market Size, By Type, 2020-2026 (USD Billion)

8.3.11.2 Market Size, By Product, 2020-2026 (USD Billion)

8.3.11.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.3.11.4 Market Size, By Application, 2020-2026 (USD Billion)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2020-2026 (USD Billion)

8.4.2 Market Size, By Type, 2020-2026 (USD Billion)

8.4.3 Market Size, By Product, 2020-2026 (USD Billion)

8.4.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.5 Market Size, By Application, 2020-2026 (USD Billion)

8.4.6 China

8.4.6.1 Market Size, By Type, 2020-2026 (USD Billion)

8.4.6.2 Market Size, By Product, 2020-2026 (USD Billion)

8.4.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.6.4 Market Size, By Application, 2020-2026 (USD Billion)

8.4.7 India

8.4.7.1 Market Size, By Type, 2020-2026 (USD Billion)

8.4.7.2 Market Size, By Product, 2020-2026 (USD Billion)

8.4.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.7.4 Market Size, By Application, 2020-2026 (USD Billion)

8.4.8 Japan

8.4.8.1 Market Size, By Type, 2020-2026 (USD Billion)

8.4.8.2 Market Size, By Product, 2020-2026 (USD Billion)

8.4.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.8.4 Market Size, By Application, 2020-2026 (USD Billion)

8.4.9 Australia

8.4.9.1 Market Size, By Type, 2020-2026 (USD Billion)

8.4.9.2 Market size, By Product, 2020-2026 (USD Billion)

8.4.9.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.9.4 Market Size, By Application, 2020-2026 (USD Billion)

8.4.10 South Korea

8.4.10.1 Market Size, By Type, 2020-2026 (USD Billion)

8.4.10.2 Market Size, By Product, 2020-2026 (USD Billion)

8.4.10.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.4.10.4 Market Size, By Application, 2020-2026 (USD Billion)

8.5 Latin America

8.5.1 Market Size, By Country 2020-2026 (USD Billion)

8.5.2 Market Size, By Type, 2020-2026 (USD Billion)

8.5.3 Market Size, By Product, 2020-2026 (USD Billion)

8.5.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.5 Market Size, By Application, 2020-2026 (USD Billion)

8.5.6 Brazil

8.5.6.1 Market Size, By Type, 2020-2026 (USD Billion)

8.5.6.2 Market Size, By Product, 2020-2026 (USD Billion)

8.5.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.6.4 Market Size, By Application, 2020-2026 (USD Billion)

8.5.7 Mexico

8.5.7.1 Market Size, By Type, 2020-2026 (USD Billion)

8.5.7.2 Market Size, By Product, 2020-2026 (USD Billion)

8.5.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.7.4 Market Size, By Application, 2020-2026 (USD Billion)

8.5.8 Argentina

8.5.8.1 Market Size, By Type, 2020-2026 (USD Billion)

8.5.8.2 Market Size, By Product, 2020-2026 (USD Billion)

8.5.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.5.8.4 Market Size, By Application, 2020-2026 (USD Billion)

8.6 MEA

8.6.1 Market Size, By Country 2020-2026 (USD Billion)

8.6.2 Market Size, By Type, 2020-2026 (USD Billion)

8.6.3 Market Size, By Product, 2020-2026 (USD Billion)

8.6.4 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.5 Market Size, By Application, 2020-2026 (USD Billion)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Type, 2020-2026 (USD Billion)

8.6.6.2 Market Size, By Product, 2020-2026 (USD Billion)

8.6.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.6.4 Market Size, By Application, 2020-2026 (USD Billion)

8.6.7 UAE

8.6.7.1 Market Size, By Type, 2020-2026 (USD Billion)

8.6.7.2 Market Size, By Product, 2020-2026 (USD Billion)

8.6.7.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.7.4 Market Size, By Application, 2020-2026 (USD Billion)

8.6.8 South Africa

8.6.8.1 Market Size, By Type, 2020-2026 (USD Billion)

8.6.8.2 Market Size, By Product, 2020-2026 (USD Billion)

8.6.8.3 Market Size, By End-User, 2020-2026 (USD Billion)

8.6.8.4 Market Size, By Application, 2020-2026 (USD Billion)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2020

9.2 F. Hoffmann-La Roche Ltd.

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 Genomic Health

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Hologic Inc.

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 Danaher

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 Argon Medical Devices, Inc.

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 BD

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 QIAGEN

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 Koninklijke Philips N.V.

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 Myriad Genetics

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Breast Cancer Diagnostics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Breast Cancer Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global breast cancer diagnostics market?

The global breast cancer diagnostics market is projected to grow from USD 4.8 billion in 2021 and is expected to reach USD 7.5 billion by 2026 at a CAGR of 6.9% from 2021 to 2026.

Who are the major vendors in the breast cancer diagnostics market?

Which region has the highest market share in the breast cancer diagnostics market?

The North American region is estimated to hold the largest share of the breast cancer diagnostics market.

What is the Covid-19 impact on the future of the breast cancer diagnostics market?

The market has become restrained during the pandemic, healthcare facilities and resources were overworked as they catered to the needs of COVID patients. Lockdowns, fear of contracting the virus, and increased regulations on patient movement have hampered the growth of the market. The increased healthcare awareness and growing demand for routine checkups in the post pandemic period as people reschedule their cancelled checkups will contribute to the growth of the market.

What are the major drivers in the breast cancer diagnostics market?

The growing awareness for breast cancer across the globe because of the increasing awareness campaigns by international organisations, increasing cases of breast cancer globally, growing diagnostics research activities due to increasing investments from the government as well as non-government sector are some of the key drivers of the growth experienced by the market.